fatty acids risk_factor_for dyslipidemia
Evidence from:
primary |
all sources
Evidence (1 sources)
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
(2013)
PMID:24285952
cited
Impaired trafficking of fatty acids ... may be causative in ... dyslipidemia
confidence: 0.94